All News
Crossing State Lines for Cancer Care
(MedPage Today) -- Many older Americans with cancer travel across state lines to receive care, according to an analysis of Medicare claims data.
Read MoreLung Cancer Screening Population in Real World May Be at Greater Risk for Harm
(MedPage Today) -- Lung cancer screening populations are older and sicker than those in the National Lung Screening Trial (NLST), a multicenter analysis showed, casting doubt on replicability in the
Read MoreHere's How Patients With Obesity Can Avoid Joint Replacement Revision
(MedPage Today) -- British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP
Read MoreTreating Generalized Myasthenia Gravis
(MedPage Today) -- Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) inhibitors, offer a new treatment paradigm, though challe
Read MoreDelays in Diagnosing Generalized Myasthenia Gravis
(MedPage Today) -- Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement i
Read MoreAn awkward moment for Pfizer’s Bourla in Washington
The Pfizer CEO at the White House, CDC vaccine efforts, and other crucial biotech news.
Read MoreSTAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.
Read MoreSTAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.
Read MoreCDC Kills Vaccine Campaign; Bird Flu Now in Rats; Pope Francis Improving
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Pharmalittle: We’re reading about RFK Jr. targeting CDC and FDA advisers, a Pfizer gene therapy program, and more
HHS Secretary Robert F. Kennedy Jr.
Read More